Key result
Chronic treatment with dronedarone increased action potential duration and effective refractory period similarly to amiodarone in rabbit atrial muscle.
Why the study?
Does dronedarone have similar acute and chronic electrophysiologic effects to amiodarone in rabbit atrial muscle?
Does dronedarone have similar acute and chronic electrophysiologic effects to amiodarone in rabbit atrial muscle?
Dronedarone exhibits similar acute and chronic electrophysiologic effects to amiodarone on rabbit atrial muscle, suggesting comparable potential against atrial arrhythmias.
Answers are grounded in this paper and cite their sources.
Supports preclinical similarity to amiodarone; leaves open clinical translation for atrial arrhythmias.
Dronedarone, a noniodinated derivative of amiodarone, is under evaluation as a potentially less toxic anti-arrhythmic alternative to amiodarone. The acute and chronic electrophysiologic effects of dronedarone and amiodarone were compared in isolated rabbit atrial muscle by microelectrode techniques. Four-week PO treatment with dronedarone or amiodarone increased action potential duration (APD90) (58 +/- 4 ms control versus 69 +/- 2 ms dronedarone, p < 0.01; 68 +/- 3 ms amiodarone, p < 0.01 for a 100-mg/kg/d dose) and effective refractory period (49 +/- 6 ms control versus 68 +/- 4 ms dronedarone, p < 0.01; 63 +/- 3 ms amiodarone, p < 0.01). The APD90 prolonged reverse rate-dependency. In contrast, acute superfusion with 10 microM dronedarone or amiodarone decreased APD90 (61 +/- 6 ms control versus 53 +/- 4 ms dronedarone, p < 0.05; 52 +/- 6 ms amiodarone, p < 0.05), effective refractory period (50 +/- 5 ms control versus 44 +/- 4 ms dronedarone, p < 0.05; 43 +/- 6 ms amiodarone, p < 0.05), and the maximum upstroke slope of the action potential (Vmax) (188 +/- 9 V/s control versus 182 +/- 11 V/s dronedarone p < 0.05; 182 +/- 11 V/s amiodarone, p < 0.05). Thus, chronic and acute electrophysiologic effects of dronedarone on rabbit atrial muscle are similar to those of amiodarone, suggesting a similar potential against atrial arrhythmias.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2002) studied Atrial arrhythmias. Dronedarone vs. Amiodarone and control was evaluated on Action potential duration (APD90) after 4-week PO treatment (p=<0.01). Chronic treatment with dronedarone increased action potential duration and effective refractory period similarly to amiodarone in rabbit atrial muscle.
Synapse has enriched 10 related papers. Consider them for comparative context: